Related Experiment Video
Updated: Jun 3, 2026

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors
Published on: May 31, 2024
Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant
Mette Bonde1, Dorte H Højland, Hans Jørn Kolmos
1Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Abstract:
The antipsychotic drug thioridazine is a candidate drug for an alternative treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in combination with the β-lactam antibiotic oxacillin. The drug has been shown to have the capability to resensitize MRSA to oxacillin. We have previously shown that the expression of some resistance genes is abolished after treatment with thioridazine and oxacillin. To further understand the mechanism underlying the reversal of resistance, we tested the expression of genes involved in antibiotic resistance and cell wall biosynthesis in response to thioridazine in combination with oxacillin. We observed that the oxacillin-induced expression of genes belonging to the VraSR regulon is reduced by the addition of thioridazine. The exclusion of such key factors involved in cell wall biosynthesis will most likely lead to a weakened cell wall and affect the ability of the bacteria to sustain oxacillin treatment. Furthermore, we found that thioridazine itself reduces the expression level of selected virulence genes and that selected toxin genes are not induced by thioridazine. In the present study, we find indications that the mechanism underlying reversal of resistance by thioridazine relies on decreased expression of specific genes involved in cell wall biosynthesis.
Insights
Thioridazine resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to oxacillin by reducing key cell wall biosynthesis genes. This antipsychotic drug offers a potential new strategy against challenging MRSA infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge.
- The antipsychotic thioridazine shows potential in combination therapy with oxacillin to overcome MRSA resistance.
- Previous studies indicated thioridazine abolishes some MRSA resistance gene expression.
Purpose of the Study:
- To elucidate the mechanism by which thioridazine reverses oxacillin resistance in MRSA.
- To investigate the impact of thioridazine and oxacillin on genes involved in antibiotic resistance and cell wall biosynthesis.
Main Methods:
- Testing gene expression in MRSA treated with thioridazine and oxacillin.
- Analyzing the expression of genes within the VraSR regulon.
- Evaluating the effect of thioridazine on virulence and toxin gene expression.
Main Results:
- Thioridazine addition reduced oxacillin-induced expression of VraSR regulon genes.
- This reduction likely weakens the bacterial cell wall, impacting oxacillin efficacy.
- Thioridazine also decreased the expression of selected virulence genes without inducing toxin genes.
Conclusions:
- The reversal of MRSA resistance by thioridazine is linked to the downregulation of specific cell wall biosynthesis genes.
- Thioridazine's multifaceted effects on gene expression present a promising therapeutic avenue against MRSA.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
